Last updated on August 2019

A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens


Brief description of study

The purpose of this study is to evaluate the clinical benefit of subcutaneous (SC) daratumumab administered in combination with standard multiple myeloma (MM) regimens in participants with MM as measured by overall response rate (ORR) or very good partial response (VGPR) or better rate.

Detailed Study Description

The hypothesis is that the addition of daratumumab administered SC to standard MM regimens will improve responses compared to response data observed in completed phase 3 studies without daratumumab. Disease evaluations will include measurements of myeloma proteins, bone marrow examinations, skeletal surveys, assessment of extramedullary plasmacytomas, and measurements of serum calcium corrected for albumin. Safety will be measured by adverse events, laboratory test results, electrocardiogram (ECGs), vital sign measurements, physical examination findings, SC injection-site assessments, and assessment of Eastern Cooperative Oncology Group (ECOG) performance status score. Study will consist of 3 phases (screening, treatment and follow-up) and duration of study is approximately 3 years.

Clinical Study Identifier: NCT03412565

Find a site near you

Start Over

University of Connecticut

Farmington, CT United States
  Connect »

Mayo Clinic in Florida

Jacksonville, FL United States
  Connect »

Watson Clinic Llp

Lakeland, FL United States
  Connect »

University of Maryland

Baltimore, MD United States
  Connect »

Karmonos Cancer Institute

Detroit, MI United States
  Connect »

Providence Cancer Center

Southfield, MI United States
  Connect »

Billings Clinic

Billings, MT United States
  Connect »

The Valley Hospital

Ridgewood, NJ United States
  Connect »

San Juan Oncology Associates

Farmington, NM United States
  Connect »

St Francis Hospital

East Hills, NY United States
  Connect »

Queens Medical Associates, PC

Fresh Meadows, NY United States
  Connect »

Northwell Health

Lake Success, NY United States
  Connect »

NYU Winthrop

Mineola, NY United States
  Connect »

Mt. Sinai School of Medicine

New York, NY United States
  Connect »

University of North Carolina

Chapel Hill, NC United States
  Connect »

Gibbs Cancer Center

Spartanburg, SC United States
  Connect »

Utah Cancer Specialists

Salt Lake City, UT United States
  Connect »

CHU Bretonneau

Tours Cedex 9, France
  Connect »

CHU Nancy Brabois

Vandoeuvre Les Nancy, France
  Connect »

Royal Bournemouth Hospital

Bournemouth, United Kingdom
  Connect »

Kent and Canterbury Hospital

Canterbury, United Kingdom
  Connect »

Manchester Royal Infirmary

Manchester, United Kingdom
  Connect »

Derriford Hospital

Plymouth, United Kingdom
  Connect »

Royal Stoke University Hospital

Stoke on Trent, United Kingdom
  Connect »

Royal Stoke University Hospital

Stoke On Trent, United Kingdom
  Connect »